These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22438980)

  • 1. Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.
    Zhang L; Yokoi F; Parsons DS; Standaert DG; Li Y
    PLoS One; 2012; 7(3):e33669. PubMed ID: 22438980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.
    Yokoi F; Dang MT; Zhou T; Li Y
    Hum Mol Genet; 2012 Feb; 21(4):916-25. PubMed ID: 22080833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models.
    Yokoi F; Dang MT; Yang G; Li J; Doroodchi A; Zhou T; Li Y
    Behav Brain Res; 2012 Feb; 227(1):12-20. PubMed ID: 22040906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome.
    Xiao J; Vemula SR; Xue Y; Khan MM; Carlisle FA; Waite AJ; Blake DJ; Dragatsis I; Zhao Y; LeDoux MS
    Neurobiol Dis; 2017 Feb; 98():52-65. PubMed ID: 27890709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition.
    Maltese M; Martella G; Imbriani P; Schuermans J; Billion K; Sciamanna G; Farook F; Ponterio G; Tassone A; Santoro M; Bonsi P; Pisani A; Goodchild RE
    Neurobiol Dis; 2017 Dec; 108():128-139. PubMed ID: 28823931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cerebellar knockdown of
    Washburn S; Fremont R; Moreno-Escobar MC; Angueyra C; Khodakhah K
    Elife; 2019 Dec; 8():. PubMed ID: 31868164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for SGCE mutations in Moroccan sporadic patients with Myoclonus-Dystonia syndrome.
    Rachad L; El Otmani H; Karkar A; El Moutawakil B; El Kadmiri N; Nadifi S
    Neurosci Lett; 2019 Jun; 703():1-4. PubMed ID: 30849405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce.
    Yokoi F; Yang G; Li J; DeAndrade MP; Zhou T; Li Y
    J Biochem; 2010 Oct; 148(4):459-66. PubMed ID: 20627944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice.
    Yokoi F; Dang MT; Li J; Li Y
    J Biochem; 2006 Jul; 140(1):141-6. PubMed ID: 16815860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric writer's cramp in myoclonus-dystonia: maternal imprinting hides positive family history.
    Gerrits MC; Foncke EM; Koelman JH; Tijssen MA
    Eur J Paediatr Neurol; 2009 Mar; 13(2):178-80. PubMed ID: 18571946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA.
    Esapa CT; Waite A; Locke M; Benson MA; Kraus M; McIlhinney RA; Sillitoe RV; Beesley PW; Blake DJ
    Hum Mol Genet; 2007 Feb; 16(3):327-42. PubMed ID: 17200151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and Molecular Properties of DYT-SGCE Myoclonus-Dystonia Patient-Derived Striatal Medium Spiny Neurons.
    Kutschenko A; Staege S; Grütz K; Glaß H; Kalmbach N; Gschwendtberger T; Henkel LM; Heine J; Grünewald A; Hermann A; Seibler P; Wegner F
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gait Impairment in Myoclonus-Dystonia (DYT-
    Haeri G; Shahidi G; Fasano A; Rohani M
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31413899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in ε-Sarcoglycan Induces a Myoclonus-Dystonia Syndrome-Like Movement Disorder in Mice.
    Li J; Liu Y; Li Q; Huang X; Zhou D; Xu H; Zhao F; Mi X; Wang R; Jia F; Xu F; Yang J; Liu D; Deng X; Zhang Y
    Neurosci Bull; 2021 Mar; 37(3):311-322. PubMed ID: 33355901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Roles of GluA2-lacking AMPA Receptor Expression in Dopamine D1 or D2 Receptor Neurons in Animal Behavior.
    Shou J; Tran A; Snyder N; Bleem E; Kim S
    Neuroscience; 2019 Feb; 398():102-112. PubMed ID: 30537522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary Myoclonus Dystonia: A Novel
    Coughlin DG; Bardakjian TM; Spindler M; Deik A
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():547. PubMed ID: 29607243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced striatal D2 receptor binding in myoclonus-dystonia.
    Beukers RJ; Booij J; Weisscher N; Zijlstra F; van Amelsvoort TA; Tijssen MA
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):269-74. PubMed ID: 18719906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese familial case of myoclonus-dystonia syndrome with a splicing mutation in SGCE.
    Wada T; Takano K; Tsurusaki Y; Miyake N; Nakashima M; Saitsu H; Matsumoto N; Osaka H
    Pediatr Int; 2015 Apr; 57(2):324-6. PubMed ID: 25868953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes.
    Tezenas du Montcel S; Clot F; Vidailhet M; Roze E; Damier P; Jedynak CP; Camuzat A; Lagueny A; Vercueil L; Doummar D; Guyant-Maréchal L; Houeto JL; Ponsot G; Thobois S; Cournelle MA; Durr A; Durif F; Echenne B; Hannequin D; Tranchant C; Brice A;
    J Med Genet; 2006 May; 43(5):394-400. PubMed ID: 16227522
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.